https://www.selleckchem.com/pr....oducts/trastuzumab.h
The key MOR intermediate *CH3OH is identified on TiO2 under operando conditions at higher potential using transient open-circuit potential measurement. To minimize the overoxidation of *CH3OH, a bimetallic Cu2O3 on TiO2 catalysts is developed, in which Cu reduces the barrier for the reaction of *CH3 and *OH and facilitates the desorption of *CH3OH. The highest faradaic efficiency of 6% is obtained using Cu-Ti bimetallic TMO.Slow waves (SWs) are globally propagating, low-frequency (0.5- to 4-Hz) oscillations that are prominent during
Like
Comment
Share
